Oncopeptides (Sweden) Price on June 27, 2024
| ONCO Stock | SEK 1.54 0.03 1.99% |
If you're considering investing in Oncopeptides Stock, it is important to understand the factors that can impact its price. As of today, the current price of Oncopeptides stands at 1.54, as last reported on the 23rd of November, with the highest price reaching 1.57 and the lowest price hitting 1.49 during the day. Oncopeptides AB maintains Sharpe Ratio (i.e., Efficiency) of -0.12, which implies the firm had a -0.12% return per unit of risk over the last 3 months. Oncopeptides AB exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncopeptides' Variance of 14.15, risk adjusted performance of (0.09), and Coefficient Of Variation of (812.67) to confirm the risk estimate we provide.
Oncopeptides Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Oncopeptides |
Sharpe Ratio = -0.123
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ONCO |
Estimated Market Risk
| 3.76 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.46 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oncopeptides is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncopeptides by adding Oncopeptides to a well-diversified portfolio.
Oncopeptides Valuation on June 27, 2024
It is possible to determine the worth of Oncopeptides on a given historical date. On June 27, 2024 Oncopeptides was worth 2.9 at the beginning of the trading date compared to the closed value of 2.78. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncopeptides stock. Still, in general, we apply an absolute valuation method to find Oncopeptides' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncopeptides where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncopeptides' related companies.
| Open | High | Low | Close | Volume | |
| 2.90 | 2.91 | 2.76 | 2.78 | 669,451 | |
06/27/2024 | 2.90 | 2.98 | 2.75 | 2.78 | 1,095,031 |
| 2.78 | 3.10 | 2.77 | 2.93 | 2,854,608 |
| Backtest Oncopeptides | | | Oncopeptides History | | | Oncopeptides Valuation | Previous | Next |
Oncopeptides Trading Date Momentum on June 27, 2024
| On June 28 2024 Oncopeptides AB was traded for 2.93 at the closing time. The highest price during the trading period was 3.10 and the lowest recorded bid was listed for 2.77 . The volume for the day was 2.9 M. This history from June 28, 2024 contributed to the next trading day price appreciation. The trading delta at closing time to the next closing price was 5.40% . The trading delta at closing time to the current price is 10.79% . |
Oncopeptides AB Fundamentals Correlations and Trends
By evaluating Oncopeptides' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncopeptides' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncopeptides financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Oncopeptides Stock history
Oncopeptides investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncopeptides is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncopeptides AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncopeptides stock prices may prove useful in developing a viable investing in Oncopeptides
Oncopeptides AB , a pharmaceutical company, develops drugs for the treatment of cancer. The company was founded in 2000 and is headquartered in Stockholm, Sweden. Oncopeptides is traded on Stockholm Stock Exchange in Sweden.
Oncopeptides Stock Technical Analysis
Oncopeptides technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Oncopeptides Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Oncopeptides AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Oncopeptides November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Oncopeptides stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncopeptides shares will generate the highest return on investment. By undertsting and applying Oncopeptides stock market strength indicators, traders can identify Oncopeptides AB entry and exit signals to maximize returns
Oncopeptides Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oncopeptides' price direction in advance. Along with the technical and fundamental analysis of Oncopeptides Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncopeptides to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (1.14) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Oncopeptides Stock Analysis
When running Oncopeptides' price analysis, check to measure Oncopeptides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncopeptides is operating at the current time. Most of Oncopeptides' value examination focuses on studying past and present price action to predict the probability of Oncopeptides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncopeptides' price. Additionally, you may evaluate how the addition of Oncopeptides to your portfolios can decrease your overall portfolio volatility.